本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soleno Therapeutics

87.20
-0.4400-0.50%
盘后87.200.00000.00%16:32 EDT
成交量:118.76万
成交额:1.04亿
市值:46.00亿
市盈率:-18.77
高:88.82
开:88.25
低:86.24
收:87.64
数据加载中...
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/28

SEC问询函

Form CORRESP - Correspondence
2023/10/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/29

重要事件披露

Form 8-K - Current report